Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the Science of Food and Agriculture|May 26, 2018
Effect of radio-frequency heating on microbial load, flavor, color, and texture profiles of Cordyceps militarisLiang Ma, Min Zhang, Shuyong Zhao
European Journal of Medicinal Chemistry|June 7, 2014
Synthesis and in vivo SAR study of indolin-2-one-based multi-targeted inhibitors as potential anticancer agentsLong Zhang, Qingmei Zheng, Yingying Yang, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitorsLong Zhang, Yingying Yang, Haojie Zhou, et al.
European Journal of Medicinal Chemistry|October 15, 2013
Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancerLong Zhang, Chuanwen Fan, Zongru Guo, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|November 19, 2021
Cross-sectional study: Relationship between serum trace elements and hypertensionZhengduo Zhang, Shuyong Zhao, Hong Wu, et al.
BMC Complementary and Alternative Medicine|March 25, 2017
The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesity-resistant rats with chronic partial sleep deprivationXin Zou, Wenya Huang, Fuer Lu, et al.
Journal of Cardiovascular Pharmacology|July 6, 2019
Two Compounds Isolated From Ganglioside GM1 Promote Angiogenesis in ZebrafishYunwei Shi, Xiaoning Wang, Yuanyuan Shi, et al.
Annals of Translational Medicine|July 18, 2022
WX-0593 combined with an epithelial growth factor receptor (EGFR) monoclonal antibody in the treatment of xenograft tumors carrying triple <i>EGFR</i> mutationsQingmei Zheng, Dongmei Chen, Xinmei Wang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 15, 2011
Long-term renal changes in the liver-specific glucokinase knockout mouse: implications for renal disease in maturity-onset diabetes of the young 2Yi Gu, Yiqing Mao, Hui Li, et al.
Investigational New Drugs|April 10, 2023
Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancerYingying Yang, Qingmei Zheng, Xinmei Wang, et al.
Pageof 2